Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.23% | 170.71 | 0.7% | $966.95m | |
| ABBV | AbbVie, Inc. | 1.75% | 140.46 | 1.9% | $842.51m | |
| PFE | Pfizer Inc. | 0.53% | 49.53 | 0.9% | $829.45m | |
| LLY | Eli Lilly & Co. | 0.47% | 302.72 | 1.1% | $749.66m | |
| MRK | Merck & Co., Inc. | 1.30% | 88.55 | 0.7% | $749.54m | |
| BMY | Bristol-Myers Squibb Co. | 2.14% | 73.67 | 1.0% | $663.79m | |
| SIGA | SIGA Technologies, Inc. | -5.19% | 22.09 | 0.0% | $391.42m | |
| AZN | AstraZeneca Plc | -1.20% | 65.24 | 1.0% | $376.90m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 5.24% | 230.04 | 8.1% | $253.91m | |
| GSK | GSK Plc | -0.52% | 40.36 | 0.3% | $216.73m | |
| HZNP | Horizon Therapeutics Plc | 1.01% | 70.30 | 5.4% | $199.78m | |
| SGEN | Seagen Inc. | 1.60% | 178.62 | 5.7% | $191.76m | |
| NVS | Novartis AG | 0.48% | 85.98 | 0.2% | $174.22m | |
| RGEN | Repligen Corp. | 2.71% | 252.94 | 6.7% | $159.97m | |
| NVO | Novo Nordisk A/S | -0.67% | 102.51 | 0.1% | $151.88m |
Company Profile
Amylyx Pharmaceuticals, Inc. operates as a biopharmaceutical company, which provides disease-modifying solutions for neurodegenerative diseases. The firm focuses on streamlined clinical development and drug discovery. It specializes in developing a proprietary therapeutic for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases that target the neuroinflammation and nerve cell death that characterize these disorders. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.